Microalbuminuria as detection in early diagnosis of nephropathy in diabetic patients
DOI:
https://doi.org/10.59169/pentaciencias.v5i3.566Keywords:
Diabetes mellitus; diagnosis; nephropathy; prevalence; proteinuria.Abstract
Diabetic kidney disease in patients with diabetes mellitus, also known as diabetic nephropathy, is one of the most common microvascular complications of the kidneys, leading to the appearance of proteinuria, which must be detected early. This research aimed to evaluate microalbuminuria for the early diagnosis of nephropathies in diabetic patients. A descriptive type documentary design was applied. A variable prevalence of renal disease or diabetic nephropathy with and without associated proteinuria was evidenced, in a frequency range of 2.78% to 68.3% of cases with proteinuria and from 8.57% to 64.86% in patient’s diabetics without proteinuria. The demographic determinants involved in the progression and mortality of kidney disease were the patient's age, sex, and genetics, as well as environmental factors that could influence the appearance of the different known kidney disease phenotypes and their progression over time. chronic kidney disease. The detection of microalbuminuria, despite reported limitations, is emerging as one of the markers of kidney injury and its use can facilitate the way of evaluating patients who may present with nephropathy.
Downloads
References
Adeva, A. (2022). Biochemical composition of the glomerular extracellular matrix in patients with diabetic kidney disease. World J Diabetes. doi: 10.4239/wjd.v13.i7.498.
Afkarian, M. (2017). Clinical Manifestations of Kidney Disease Among US Adults with Diabetes. JAMA. doi: 10.1001/jama.2016.10924.
Besse, D. (2021). Aspectos clínicos y epidemiológicos relacionados con la microalbuminuria en pacientes con diabetes mellitus de tipo 2. MEDISAN.
Candler, T. (2018). Continuing rise of Type 2 diabetes incidence in children and young people in the UK. Diabet Med. doi: 10.1111/dme.13609.
Carrillo, L. (2019). The risk of mortality among people with type 2 diabetes in Latin America: A systematic review and meta-analysis of population-based cohort studies. Diabetes Metab Res Rev.
Carvajal, C. (2018). Proteinuria y microalbuminuria. Med Leg Costa Rica.
Chen, W. (2019). Addressing Racial Disparity in the Progression of Chronic Kidney Disease: Prescribe More Fruits and Vegetables? Am J Nephrol. doi: 10.1159/000487716.
Crasto, W. (s.f.). Prevalence and progression of diabetic nephropathy in South Asian, white European and African Caribbean people with type 2 diabetes: A systematic review and meta-analysis. 2020.
Estremadoyro, S. (2020). Asociación entre albuminuria y mortalidad en adultos mayores con pie diabético en el servicio de clínica de día en el Centro Médico Naval (2010-2015). Acta Médica Peruana.
Fabian, J. (2019). Methods and reporting of kidney function: a systematic review of studies from sub-Saharan Africa. Clin Kidney J.
Gao, B. (2019). Clinical features and long-term outcomes of diabetic kidney disease - A prospective cohort study from China. J Diabetes Complications, 39 - 45.
González, M. (2019). Albuminuria como factor predictor de nefropatía hipertensiva. Revista Electrónica Dr Zoilo E Marinello Vidaurreta.
Harding, K. (2018). Current State and Future Trends to Optimize the Care of Chronic Kidney Disease in African Americans. Am J Nephrol. doi: 10.1159/000479481.
Kapoula, G. (2021). Diagnostic Accuracy of Neutrophil Gelatinase-Associated Lipocalin for Predicting Early Diabetic Nephropathy in Patients with Type 1 and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis. J Appl Lab Med.
Luo, W. (2021). ncreased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. doi: 10.1186/s13098-021-00624-9.
Mansoor , G. (2020). Increased Expression of Circulating Stress Markers, Inflammatory Cytokines and Decreased Antioxidant Level in Diabetic Nephropathy. Medicina (Kaunas).
Penno, G. (2018). Renal Insufficiency and Cardiovascular Events (RIACE) Study Group. Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes. The Renal Int.
Vergara, A. (2019). Enfermedad Renal Diabética: Albuminuria y Progresión. Nefrología al día.
Yamanouchi, M. (2020). Nonproteinuric diabetic kidney disease. Clin Exp Nephrol. doi: 10.1007/s10157-020-01881-0, 573 - 581.
Yokoyama, H. (2019). The Prognosis of Patients with Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor. Implication of the Effe.
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Revista Científica Arbitrada Multidisciplinaria PENTACIENCIAS - ISSN 2806-5794.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

